{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:21Z","timestamp":1792096881237,"version":"4.4.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC- StG639961"],"award-info":[{"award-number":["ERC- StG639961"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 2722"],"award-info":[{"award-number":["FOR 2722"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1310"],"award-info":[{"award-number":["CRC 1310"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1279"],"award-info":[{"award-number":["CRC 1279"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.immuni.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T10:34:35Z","timestamp":1701254075000},"page":"2803-2815.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants"],"prefix":"10.1016","volume":"56","author":[{"given":"Michael","family":"Korenkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Zehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Cohen-Dvashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Borenstein-Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kottege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Janicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vanshylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gruell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Diskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kreer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-1792","authenticated-orcid":false,"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2023.11.004_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri2941","article-title":"Recombination centres and the orchestration of V(D)J recombination","volume":"11","author":"Schatz","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib2","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0092-8674(02)00675-X","article-title":"The mechanism and regulation of chromosomal V(D)J recombination","volume":"109","author":"Bassing","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00042","article-title":"Secondary mechanisms of diversification in the human antibody repertoire","volume":"4","author":"Briney","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.aad3439","article-title":"Visualizing antibody affinity maturation in germinal centers","volume":"351","author":"Tas","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12640","article-title":"Generation of memory B cells and their reactivation","volume":"283","author":"Inoue","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2023.11.004_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52384","article-title":"Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics","volume":"8","author":"Durham","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2023.11.004_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ed7c0148-97eb-4416-824d-6e6d1aaeceef","article-title":"Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs","volume":"9","author":"Hoot","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2023.11.004_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11371","article-title":"Structural and genetic basis for development of broadly neutralizing influenza antibodies","volume":"489","author":"Lingwood","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41423-020-0403-1","article-title":"Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody","volume":"18","author":"Yi","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9223","article-title":"Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody","volume":"6","author":"Ying","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.11.004_bib14","article-title":"Minimally mutated HIV-1 broadly neutralizing antibodies to guide reductionist vaccine design","volume":"12","author":"Jardine","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2023.11.004_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.chom.2018.04.018","article-title":"Functional relevance of improbable antibody mutations for HIV broadly neutralizing antibody development","volume":"23","author":"Wiehe","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.11.004_bib16","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.4049\/jimmunol.1202964","article-title":"Reversion of somatic mutations of the respiratory syncytial virus\u2013specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency","volume":"190","author":"Bates","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2021.12.003","article-title":"Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization","volume":"55","author":"Weber","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2020.09.035","article-title":"Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy","volume":"183","author":"Du","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib24","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model","volume":"183","author":"Kreye","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2020.06.044","article-title":"Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients","volume":"182","author":"Kreer","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib37","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S2213-2600(22)00215-6","article-title":"Tixagevimab\u2013cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial","volume":"10","author":"Holland","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib39","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108163","article-title":"REGEN-COV antibody combination and outcomes in outpatients with Covid-19","volume":"385","author":"Weinreich","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib41","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab\u2013Cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S2213-2600(22)00180-1","article-title":"Efficacy and safety of intramuscular administration of tixagevimab\u2013cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"Montgomery","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib43","series-title":"Casirivimab and Imdevimab in Patients Admitted to Hospital with COVID-19 (RECOVERY): a Randomised, Controlled, Open-Label, Platform Trial (Infectious Diseases (except HIV\/AIDS))","author":"Horby","year":"2021"},{"key":"10.1016\/j.immuni.2023.11.004_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib45","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib47","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib49","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","article-title":"The antigenic anatomy of SARS-CoV-2 receptor binding domain","volume":"184","author":"Dejnirattisai","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib50","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.immuni.2020.06.001","article-title":"Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation","volume":"53","author":"Seydoux","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8\u00a0months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib55","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","article-title":"Maturation and persistence of the anti-SARS-CoV-2 memory B cell response","volume":"184","author":"Sokal","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg6916","article-title":"Prolonged evolution of the human B cell response to SARS-CoV-2 infection","volume":"6","author":"Sakharkar","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib57","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.immuni.2021.07.008","article-title":"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations","volume":"54","author":"Muecksch","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19231-9","article-title":"Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation","volume":"11","author":"Hurlburt","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.11.004_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24123-7","article-title":"Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.11.004_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108950","article-title":"Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class","volume":"35","author":"Rapp","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.11.004_bib61","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.chom.2022.07.002","article-title":"SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns","volume":"30","author":"Gruell","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.11.004_bib62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib64","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2022.03.019","article-title":"A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd6990","article-title":"Stereotypic neutralizing V H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals","volume":"13","author":"Kim","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109604","article-title":"Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals","volume":"36","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2023.11.004_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-022-05644-7","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib68","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.immuni.2023.04.012","article-title":"Immunological imprinting: understanding COVID-19","volume":"56","author":"Koutsakos","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib69","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","article-title":"CoV-AbDab: the coronavirus antibody database","volume":"37","author":"Raybould","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2023.11.004_bib70","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/s41467-023-42906-y","article-title":"Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals","volume":"14","author":"Kreer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.11.004_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/science.abh1766","article-title":"Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants","volume":"373","author":"Wang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo3425","article-title":"Antibodies induced by an ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1","volume":"7","author":"Windsor","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.abm5835","article-title":"SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies","volume":"375","author":"Reincke","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chom.2021.12.010","article-title":"Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers","volume":"30","author":"Vanshylla","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.11.004_bib74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2013.03.018","article-title":"Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization","volume":"153","author":"Klein","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/f1f8c791-61e9-45c6-a455-92c6dadf9f06","article-title":"The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies","volume":"9","author":"Sok","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2023.11.004_bib76","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13764","article-title":"Rapid development of broadly influenza neutralizing antibodies through redundant mutations","volume":"516","author":"Pappas","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib77","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1073\/pnas.1802378115","article-title":"Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors","volume":"115","author":"Aleman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.11.004_bib78","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"Ng","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.11.004_bib79","article-title":"Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection","volume":"12","author":"Song","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.11.004_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150613","article-title":"Seasonal coronavirus\u2013specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19","volume":"131","author":"Aguilar-Bretones","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2023.11.004_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103951","article-title":"No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults","volume":"25","author":"Ercanoglu","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.immuni.2023.11.004_bib82","doi-asserted-by":"crossref","first-page":"E2567","DOI":"10.1073\/pnas.1406974111","article-title":"Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity","volume":"111","author":"Sabouri","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.11.004_bib83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.it.2006.06.007","article-title":"Why do B cells mutate their immunoglobulin receptors?","volume":"27","author":"Longo","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2023.11.004_bib86","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib87","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.immuni.2021.08.013","article-title":"A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants","volume":"54","author":"Schmitz","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.11.004_bib88","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.11.004_bib102","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.chom.2021.04.015","article-title":"Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans","volume":"29","author":"Vanshylla","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2023.11.004_bib90","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.immuni.2023.11.004_bib91","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.immuni.2023.11.004_bib92","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biot.201400821","article-title":"Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines","volume":"10","author":"Kowarz","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.immuni.2023.11.004_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.immuni.2023.11.004_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/28.1.292","article-title":"Codon usage tabulated from international DNA sequence databases: status for the year 2000","volume":"28","author":"Nakamura","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2023.11.004_bib106","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2023.11.004_bib104","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.immuni.2023.11.004_bib95","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2023.11.004_bib96","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gki065","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"33","author":"Lefranc","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2023.11.004_bib105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2023.11.004_bib107","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.immuni.2023.11.004_bib97","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2144\/00286ir01","article-title":"The sequence manipulation Suite: JavaScript programs for analyzing and formatting protein and DNA sequences","volume":"28","author":"Stothard","year":"2000","journal-title":"BioTechniques"},{"key":"10.1016\/j.immuni.2023.11.004_bib98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-2836(84)90309-7","article-title":"Analysis of membrane and surface protein sequences with the hydrophobic moment plot","volume":"179","author":"Eisenberg","year":"1984","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2023.11.004_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2020.01.010","article-title":"Restriction of HIV-1 escape by a highly broad and potent neutralizing antibody","volume":"180","author":"Schommers","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.11.004_bib100","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1038\/s41596-021-00554-w","article-title":"Effective high-throughput isolation of fully human antibodies targeting infectious pathogens","volume":"16","author":"Gieselmann","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2023.11.004_bib101","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"Ehrhardt","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2023.11.004_bib103","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761323004855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761323004855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:12:04Z","timestamp":1778587924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761323004855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":107,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1074761323004855"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2023.11.004","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}